Last reviewed · How we verify
Study of Clinical and Laboratory Predictors of Hepatocellular Carcinoma in Post-HCV Cirrhotic Patients After Sustained Virologic Response.
This study aims to identify clinical and laboratory factors that predict the occurrence of hepatocellular carcinoma (HCC) in Egyptian cirrhotic patients after achieving a sustained virologic response (SVR) to hepatitis C virus (HCV) treatment. This is a retrospective, two-center, case-control study that will include 132 cases and 264 controls. Variables to be analyzed include demographics, liver disease status, metabolic comorbidities, lifestyle factors, medications, as well as laboratory parameters and non-invasive scoring systems.
Details
| Lead sponsor | Sohag University |
|---|---|
| Status | NOT_YET_RECRUITING |
| Enrolment | 400 |
| Start date | 2025-08 |
| Completion | 2025-11 |
Conditions
- HCC - Hepatocellular Carcinoma
Primary outcomes
- occurrence of hepatocellular carcinoma (HCC) — from SVR12 achievement to 6-9 years later (time of data collection)
measure occurrence of HCC in post-HCV liver cirrhosis after achieving SVR, by comparing cases to controls
Countries
Egypt